000 | 01748 a2200517 4500 | ||
---|---|---|---|
005 | 20250517115117.0 | ||
264 | 0 | _c20170123 | |
008 | 201701s 0 0 eng d | ||
022 | _a1600-0463 | ||
024 | 7 |
_a10.1111/apm.12602 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aChao, Ting-Ting | |
245 | 0 | 0 |
_aCIP2A is a poor prognostic factor and can be a diagnostic marker in papillary thyroid carcinoma. _h[electronic resource] |
260 |
_bAPMIS : acta pathologica, microbiologica, et immunologica Scandinavica _cDec 2016 |
||
300 |
_a1031-1037 p. _bdigital |
||
500 | _aPublication Type: Evaluation Study; Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAutoantigens _xanalysis |
650 | 0 | 4 |
_aBiomarkers, Tumor _xanalysis |
650 | 0 | 4 | _aBlotting, Western |
650 | 0 | 4 |
_aCarcinoma _xdiagnosis |
650 | 0 | 4 | _aCarcinoma, Papillary |
650 | 0 | 4 | _aDisease Progression |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunohistochemistry |
650 | 0 | 4 | _aIntracellular Signaling Peptides and Proteins |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMembrane Proteins _xanalysis |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aROC Curve |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aSurvival Analysis |
650 | 0 | 4 | _aThyroid Cancer, Papillary |
650 | 0 | 4 |
_aThyroid Neoplasms _xdiagnosis |
700 | 1 | _aMaa, Hung-Chune | |
700 | 1 | _aWang, Cheng-Yi | |
700 | 1 | _aPei, Dee | |
700 | 1 | _aLiang, Yao-Jen | |
700 | 1 | _aYang, Yi-Feng | |
700 | 1 | _aChou, Shuo-Jiun | |
700 | 1 | _aChen, Yen-Lin | |
773 | 0 |
_tAPMIS : acta pathologica, microbiologica, et immunologica Scandinavica _gvol. 124 _gno. 12 _gp. 1031-1037 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/apm.12602 _zAvailable from publisher's website |
999 |
_c26436423 _d26436423 |